124 related articles for article (PubMed ID: 2106179)
1. The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression.
Markmann JF; Tomaszewski J; Posselt AM; Levy MM; Woehrle M; Barker CF; Naji A
Transplantation; 1990 Feb; 49(2):272-7. PubMed ID: 2106179
[TBL] [Abstract][Full Text] [Related]
2. Increased islet allograft survival after extended culture by a mechanism other than depletion of donor APCs. Lack of correlation between the elimination of donor MHC class II-positive accessory cells and increased transplantability.
Ketchum RJ; Moore WV; Hegre OD
Transplantation; 1992 Aug; 54(2):347-51. PubMed ID: 1496545
[TBL] [Abstract][Full Text] [Related]
3. Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival.
Bretzel RG; Flesch BK; Brennenstuhl G; Greiner I; Hering BJ; Woehrle M; Federlin K
Acta Diabetol; 1993; 30(1):49-56. PubMed ID: 8329731
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts.
Markmann JF; Jacobson JD; Kiumura H; Choti MA; Hickey WF; Fox IJ; Silvers WK; Barker CF; Naji A
Transplantation; 1989 Sep; 48(3):478-86. PubMed ID: 2571205
[TBL] [Abstract][Full Text] [Related]
5. Islet transplantation in experimental diabetes of the rat. XIII. Cryopreservation reduces MHC class II but not class I antigens of rat pancreatic islets.
Flesch BK; Entenmann H; Milde K; Bretzel RG; Federlin K
Horm Metab Res; 1991 Jan; 23(1):1-6. PubMed ID: 1707849
[TBL] [Abstract][Full Text] [Related]
6. Activation of intraislet lymphoid cells causes destruction of islet cells.
Lacy PE; Finke EH
Am J Pathol; 1991 May; 138(5):1183-90. PubMed ID: 1902627
[TBL] [Abstract][Full Text] [Related]
7. Studies of privileged sites and islet transplantation.
Barker CF; Markmann JF; Posselt AM; Naji A
Transplant Proc; 1991 Aug; 23(4):2138-42. PubMed ID: 1871831
[No Abstract] [Full Text] [Related]
8. Transplantation of purified islet cells in diabetic rats. II. Immunogenicity of allografted islet beta-cells.
Pipeleers DG; Pipeleers-Marichal M; Vanbrabandt B; Duys S
Diabetes; 1991 Jul; 40(7):920-30. PubMed ID: 2060728
[TBL] [Abstract][Full Text] [Related]
9. Allotransplantation of culture-isolated neonatal rat islet tissue. Absence of MHC class II positive antigen-presenting cells in nonimmunogenic islets.
Hegre OD; Ketchum RJ; Popiela H; Eide CR; Meloche RM; Serie JR; Moore WV
Diabetes; 1989 Feb; 38(2):146-51. PubMed ID: 2492474
[TBL] [Abstract][Full Text] [Related]
10. The failure of intrathymic transplantation of nonimmunogenic islet allografts to promote induction of donor-specific unresponsiveness.
Campos L; Posselt AM; Deli BC; Mayo GL; Pete K; Barker CF; Naji A
Transplantation; 1994 Mar; 57(6):950-3. PubMed ID: 8154045
[TBL] [Abstract][Full Text] [Related]
11. Modulation of MHC class I antigen decreases pancreatic islet immunogenicity.
Stock PG; Ascher NL; Chen S; Bumgardner GL; Field MJ; Sutherland DE
J Surg Res; 1989 Apr; 46(4):317-21. PubMed ID: 2649742
[TBL] [Abstract][Full Text] [Related]
12. The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.
Terasaka R; Lacy PE; Hauptfeld V; Bucy RP; Davie JM
Diabetes; 1986 Jan; 35(1):83-8. PubMed ID: 3079714
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex antigens and murine islet allograft survival.
Kneteman NM; Halloran PF; Sanden WD; Wang T; Seelis RE
Transplantation; 1991 Jan; 51(1):247-51. PubMed ID: 1987695
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
15. Synergy of class I and class II MHC deficiency (C1D and C2D) islets and early short-term suppression in achieving long-term islet graft survival and tolerance induction.
Pittman K; Berzina P; Contreras J; Bilbao G; Thomas F; Thomas J
Transplant Proc; 1999; 31(1-2):635-6. PubMed ID: 10083271
[No Abstract] [Full Text] [Related]
16. Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on beta cells.
Kuttler B; Hartmann A; Wanka H
Transplantation; 2002 Aug; 74(4):440-5. PubMed ID: 12352900
[TBL] [Abstract][Full Text] [Related]
17. The influence of MHC-compatible and MHC-incompatible antigen-presenting cells on the survival of MHC-compatible cultured murine keratinocyte allografts.
Ramrakha PS; Sharp RJ; Yeoman H; Stanley MA
Transplantation; 1989 Oct; 48(4):676-80. PubMed ID: 2678636
[TBL] [Abstract][Full Text] [Related]
18. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
19. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
